内基质瘤:一个罕见的病例报告和系统审查
Shuyue Song1, Yuyang Zhao1, Yiquan Wang1
1School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
Medicine
|February 24, 2025
概括
化介质瘤 (PMTs) 是一种罕见的内瘤,常常被误诊. 早期诊断和手术切除对于成功治疗和症状缓解至关重要.
科学领域:
- 神经外科 神经外科
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 基介质瘤 (PMTs) 是一种罕见的新生体,可能涉及内.
- 它们的发病率低,不特定的症状和多样化的外观导致频繁的误诊.
研究的目的:
- 报告一个罕见的内PMT病例,发生在后脑.
- 系统地审查和总结关于内PMTs的现有文献.
主要方法:
- 通过病理学检查确认了诊断,整合了临床,实验室和成像数据.
- 进行了系统的文献审查,以收集以前报告的病例的数据.
主要成果:
- 患者接受了多学科咨询和手术切除瘤.
- 手术后,患者的实验室值正常化,症状改善,并恢复了行动能力.
结论:
- 由于PMT的罕见性,缺乏确定的诊断和治疗标准.
- 快速识别,准确诊断和完整的手术切除对于最佳结果至关重要.
- 不完全切除可能需要辅助疗法来管理复发和持续症状.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...


